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معدل االصابه بالنوع الثاين من مرض السكري بني أطفال مرضى السكري 
مبحافظة املنيا يف مصر
ب�شمة علي ،�شمري عبد اهلل، اأحالم عبد اهلل، حممود ح�شني
العامة يف جميع  لل�شحة  قلق متزايد  اأ�شبح م�شدر  االأطفال واملراهقني  )T2DM( يف  ال�شكري  داء  الثاين من  النوع  الهدف:  امللخ�ص: 
اأنحاء العامل. الهدف: تهدف هذه الدرا�شة اإىل تقدير ن�شبة T2DM بني اأطفال مر�شى ال�شكري يف حمافظة املنيا يف م�رس، و الك�شف عن 
عوامل اخلطر ذات ال�شلة. الطريقة: �شملت الدرا�شه 210 من االأطفال املر�شى بال�شكري يف حمافظة املنيا الذين خ�شعوا للفح�س البدين 
والفحو�س املخربية. والأخذ تاريخهم الطبي الدقيق. النتائج: وجد T2DM يف 28 مري�شا )%13.3(، و كان حا�رسا ب�شكل ملحوظ يف 
18 من االإناث )%64.3( حيث 20 )%17.4( منهم لديهم تاريخ عائلي اإيجابي من DM. وكان موؤ�رس اخلطوط املئوية لكتلة اجل�شم 
وحميط اخل�رس يف مر�شى T2DM اأعلى بكثري باعتبار العمر واجلن�س من مر�شى T1DM. اأي�شا كانت م�شتويات الهيموجلوبني % 
اإيجابية �شعيفة ذات  T1DM. واأخريا كان هناك ارتباطات  T2DM من مر�شى  اأعلى بكثري يف  C-الببتيد  A1c و الكول�شرتول و 
داللة اإح�شائية بني م�شتوى C-الببتيد و موؤ�رس كتلة اجل�شم وحميط اخل�رس. اخلال�سة: مل يعد مر�س T2DM ي�شيب البالغني فقط ولكن 
ميكن اأي�شا اأن يحدث يف االأطفال واملراهقني. وت�شري النتائج اىل اأن ال�شمنة، واجلن�س االأنثوي ووجود تاريخ عائلي اإيجابي من DM هي 
عوامل اخلطر لالإ�شابة ب T2DM. اأي�شا كان املر�شى الذين يعانون من T2DM االأكرث فقدا لل�شيطرة على ارتفاع ن�شبة �شكر الدم و 
الكول�شرتول من امل�شابني باأنواع مر�س ال�شكري االأخرى.
مفتاح الكلمات: مر�س ال�شكري؛ النوع الثاين؛ االأطفال؛ املراهقني؛ C-الببتيد؛ موؤ�رس كتلة اجل�شم؛ الهيموغلوبني A؛ املت�شّكر؛ الكول�شرتول؛ م�رس.
abstract: Objectives: Type 2 diabetes mellitus (T2DM) in children and adolescents is becoming an increasingly 
important public health concern throughout the world. This study aimed to estimate the frequency of T2DM 
among diabetic young people in El-Minia Governorate, Egypt, and to detect its risk factors. Methods: A total of 210 
diabetic patients under 18 years old in Minia Governorate were included in the study and underwent a thorough 
history-taking, a physical examination and laboratory investigations. Results: T2DM was present in 28 patients 
(13.3%); it was significantly present in 18 females (64.3%) and 20 (71.4%) of them had a positive family history of 
DM. T2DM patients had significantly higher BMI and waist circumference centiles for age and sex than those with 
T1DM. Also, haemoglobin A1c %, serum C-peptide and cholesterol levels were significantly higher in T2DM than 
T1DM patients. Finally, there were weak significant positive correlations between C-peptide level and both BMI 
and waist circumference. Conclusion: T2DM is no longer a disease of adults but can also occur in children and 
adolescents. The results suggested that obesity, female gender and a positive family history of DM are risk factors for 
T2DM. Also, patients with T2DM had poorer glycaemic control and hypercholesterolemia than those with other 
types of diabetes.
Keywords: Diabetes Mellitus, Type 2; Child; Adolescent; C-Peptide; Body Mass Index; Hemoglobin A, Glycosylated; 
Cholesterol; Egypt.
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Advances in Knowledge
- In this study, obesity, female gender and a positive family history of diabetes mellitus were risk factors for type 2 diabetes mellitus 
(T2DM). 
- Also, patients with T2DM had poorer glycaemic control and hypercholesterolemia.
Application to Patient Care
- Clinicians need alerting to the possibility of non-type 1 diabetes occurring in childhood, and especially to considering the possibility of 
T2DM.
- T2DM is often associated with risk factors for cardiovascular disease that may already be present at the time of diagnosis. Therefore, 
prevention and treatment strategies need to be initiated, for example obesity management programmes for obese children, especially 
those with family history of diabetes.
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Diabetes mellitus (DM) is a group of metabolic diseases characterised by chronic hyperglycaemia resulting from 
defects in insulin secretion, insulin action, or both.1 
There are two major types of diabetes, type 1 DM 
(T1DM) where there is autoimmune destruction 
of the pancreas that renders it incapable of making 
insulin. In type 2 DM (T2DM), patients can still 
produce insulin, but either not in a sufficient amount 
to meet their needs, or their body has become 
resistant to its effects with a compensatory increase 
in insulin production and release that can also end 
in beta cell damage.2 Non-insulin-dependent DM 
(T2DM) in children and adolescents is becoming 
an important public health concern throughout 
the world.3 Although T2DM is widely diagnosed 
in adults, its frequency has markedly increased in 
the paediatric age group over the past two decades. 
Depending on the population studies, T2DM now 
represents 8–45% of all new cases of diabetes 
reported among children and adolescents.4 
Therefore, this study aimed to estimate the 
frequency of T2DM among diabetic children and 
adolescents in Minia Governorate, Egypt, and to 
detect its risk factors in this community.
Methods
This study was carried out in the period from 
January 2010 to December 2010. It included 210 
patients on regular follow-up in the diabetes 
outpatient’s clinic at Minia University Children 
Hospital, Minia Governate, Egypt. The subjects 
were 124 (59%) females and 86 (41%) males. Their 
ages ranged from 1 to 18 years, with a mean age of 
11.3 ± 4.4 years.
The cases were classified into 2 groups according 
to their fasting serum C-peptide levels. Group I 
(T1DM) included those with a fasting C-peptide 
level of <0.2 ng/ml, and Group II (T2DM) 
those with a fasting C-peptide level of 0.2 to ≥3.5 ng/
ml.3–5 Written consent was obtained for each subject 
after approval of the study by the ethical committee 
of the Minia University Medical Faculty. All 
patients included in this study underwent a 
thorough history-taking and a complete 
physical examination including anthropometric 
measurements. Laboratory investigations included 
testing fasting C-peptide levels by the enzyme- 
linked immunosorbent assay (ELISA) technique 
(normal paediatric range 0.2–3.5 ng/ml),5 
haemoglobin A1(HbA1),6 lipid profile (triglycerides 
[TG] with normal level up to 150 mg/dl7 and serum 
cholesterol level with normal level up to 220 mg/
dl in paediatric patients).8 Both of the latter were 
assayed by using a fully automated clinical chemistry 
auto-analyser system Konelab 20i (Thermo Fisher 
Scientific Inc., Waltham, Massachusetts, USA).
The data were coded and verified prior to 
data entry. The Statistical Package for the Social 
Sciences (SPSS), Version 13 for Windows (IBM 
Corp., Chicago, Illinois, USA) was used for data 
entry and analysis. Descriptive statistics were 
calculated for qualitative data using the Chi-square 
test. For quantitative data, the student’s t-test (for 
two groups) was used. The Z test was used to 
compare proportions and correlations; P values of 
less than 0.05 were considered to indicate statistical 
significance.9
Results
This study aimed to estimate the frequency of 
T2DM among diabetic children and adolescents 
in Minia Governate. The frequency of T2DM 
(Group II) was found to be 13.3% (28/210) while 
T1DM (Group I) represented 86.7% (182/210) of 
the study population. Table 1 shows that Group 
II subjects were significantly older, had a longer 
disease duration, and a positive family history of 
DM compared to Group I where P <0.05. Moreover, 
there were significantly more females than males 
with T2DM (64.3% versus 58.2%). On the other 
hand, there was a non-significant difference 
between them as regarding the age of onset of 
the disease. As to the clinical findings, there was 
a significant difference in body mass index (BMI) 
percentile between Group I and Group II patients 
- Because of the relatively recent recognition of T2DM in the paediatric age group, many children with new onset T2DM may be 
misclassified as having T1DM.
- Conversely, as average weight increases in the population, overweight adolescents with autoimmune diabetes may be misdiagnosed as 
having T2DM. 
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with most patients in Group II (71.4%) having 
a BMI of 25‒75% versus 33% in Group I where 
P <0.05. Moreover, patients in Group II had a highly 
significant higher waist circumference than those in 
Group I. The laboratory investigations revealed that 
HbA1c % and cholesterol levels were significantly 
higher in Group II subjects compared to Group 
I where P <0.05. On the other hand, there was 
insignificant difference between the two groups as 
regards TG [Table 2].
Concerning the different correlations, this study 
found that there were weak positive significant 
correlations between C-peptide levels (ng/ml) and 
BMI on centile (r = 0.24, P value at 0.0001 was 
significant). 
Discussion
The prevalence of T2DM varies among different 
child and adolescent populations; it was first 
described in Pima Indian adolescents of Arizona, 
USA, in 1979.10 Among Japanese school children, 
the prevalence of type 2 diabetes has increased in 
20 years, from 2 to 76 per 100,000 individuals.11 It 
was subsequently reported among various minority 
non-Caucasian ethnic groups, for example in 
the USA, Canada, Australia, New Zealand and 
among children from Japan, Hong Kong, Libya and 
Bangladesh,12 as well as in Asian and Arab children 
in the UK.13
As regards the results of the present study, the 
frequency of T2DM was 13.3% while T1DM was 
represented in 86.7% of patients. This result was in 
approximate agreement with the result of another 
Egyptian study which was performed by Elsamahy 
et al., who demonstrated that 88.2% of children 
and adolescents included in their study had T1DM 
and only 11.8% had T2DM.14 Another study, 
performed by Moussa et al. in Kuwait, revealed 
that T2DM was present in 11.5% of all school 
children in Kuwait.15 Contrary to our results, 
Dabelea et al.16 found that the majority of diabetics 
among the Navajo youth had T2DM (80.4%) 
although autoimmune T1DM was present in 19.6% 
of the studied cases, especially among younger 
children. However, the current study found that 
the Group II T2DM subjects were significantly 
older than those in Group I with T1DM [Table 1]. 
This might be due to pubertal insulin resistance, 
attributed to increased growth hormone secretion 
during puberty and not to sex hormone secretion.17 
This result was in agreement with the result obtained 
from the two studies done by Elsamahy et al.14 and 
Moussa et al.15 Also, our result is in agreement with 
Table 1: Comparison of type 1 and type 2 diabetes 
mellitus (T1DM and T2DM) patients’ demographic 
and clinical data
Characteristic Group     P  
value
    Group I 
    (t1DM) 
   n = 182
    Group II 
    (t2DM) 









Age of onset of 
disease (years) 
mean ± SD




39.7 ± 40.7 71.3 ± 42.01 0.0001*
Gender, n (%)
   Male 








Family history of 
DM, n (%)
   Positive












   <5 
   5–25
   >25–75 
   85–95





























SD = standard deviation; DM = diabetes mellitus; * = significant.
Table 2: Comparison of laboratory parameters of 











0.13 ± 0.04 4.2 ± 3.3 0.04*
Mean HbA1c 
(%)








125.1 ± 182.2 144.5 ± 54.1 0.5
* = significant; HbA1c = haemoglobin A1c.
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that of the study performed by Fagot-Campagna et 
al.18 who found that the peak age of presentation of 
T2DM was around 13‒14 years; this corresponds to 
late puberty, with females reaching this stage one 
year earlier than males. 
Further, a highly significant difference was 
found between Group I and Group II as regards 
gender distribution; 64.3% of Group II were females 
whereas 58.2 % were males (P = 0.04). This result is 
in agreement with the results obtained by Kitagawa 
et al.11 and Kadiki et al.19 who concluded that female 
children and adolescents were more susceptible to 
the risk of developing T2DM. In contrast to our 
result, Moussa et al.15 found that the prevalence of 
T2DM was higher in males than females. Further, 
most of our patients with T2DM (71.4% versus 
47.3% of those with T1DM) had a positive family 
history of DM with a significant difference between 
them. This result was in agreement with studies by 
Haines et al.,20 Elsamahy et al.,14 Moussa et al.15 and 
Mayer-Davis et al.21 This could be explained by the 
fact that the patients’ familial predisposition could 
be related to impaired insulin action as pre-pubertal 
healthy children; those with a family history of 
T2DM had a nearly 25% lower in vivo insulin 
sensitivity compared to cross-matched children 
without a family history of T2DM.22 
Concerning anthropometric measurements, 
it was found that most of the patients in Group 
II (71.4%) had a BMI of >25‒75% versus 33% of 
Group I with a significant difference between 
them. This could be explained by the hypothesis 
which postulated that obesity mediated insulin 
resistance.23 Moreover, the patients in Group II 
had a significantly higher waist circumference than 
those in Group I. This result was in agreement with 
the result obtained by Dabelea et al.16 and could be 
explained by the fact that the amount of visceral 
fat is directly correlated with insulinemia and 
negatively with insulin sensitivity.18 
Concerning the laboratory investigations, mean 
C-peptide levels were significantly higher among 
Group II compared to Group I. Moreover, Group 
II had significantly higher levels of HbA1c % and 
cholesterol than Group I. This could be explained 
by the fact that poor glycaemic control among those 
with T2DM contributes substantially to a high lipid 
profile.24,25 This result was in agreement with the 
results obtained by Dabelea et al.16 and Mayer-Davis 
et al.21 As regards the different correlations, there 
was a weak positive significant correlation between 
C-peptide levels and BMI on centile; this could be 
explained by the fact that obesity mediated insulin 
resistance with a subsequently elevated C-peptide 
level.23
This study has the limitation that autoantibody 
screening was not performed which might have 
supported the diagnosis of T2DM. Diabetes 
autoantibody testing should be considered for all 
paediatric patients with the clinical dignosis of 
T2DM because of the islet cell autoimmunity in 
otherwise ‘typical’ T2DM. However, this study may 
provide a basis for further and wider studies in 
Egypt and elsewhere to detect and evaluate T2DM 
in children. 
Conclusion
T2DM is no longer solely a disease of adults but 
can also occur in children and adolescents. This 
study suggested that children and adolescents at 
risk for T2DM and metabolic syndromes included 
those of female gender, with obesity and having 
a positive family history of DM. Also, patients 
with T2DM had poorer glycaemic control and 
hypercholesterolemia.
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